NUVATION BIO INC.

Insiders Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Market Closed - Nyse Other stock markets 21:00:04 16/05/2024 BST			5-day change	1st Jan Change
3.42 ^USD	+3.64%		+6.21%	+126.49%

05-14	Nuvation Bio Q1 Loss Narrows; Shares Fall After Hours	MT
05-14	Nuvation Bio Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nuvation Bio Inc. Announces Appointment of Directors	04-10	CI
Nuvation Bio Inc. Appoints Colleen Sjogren as Chief Commercial Officer	03-28	CI
Nuvation Bio Inc. Announces Appointment of Robert Mashal to Its Board of Directors	01-08	CI
Nuvation Bio Inc. Announces Resignation of Oleg Nodelman from Board of Directors	12-14	CI
Nuvation Bio Inc. Appoints Moses Makunje as Principal Accounting Officer and Principal Financial Officer	11-27	CI
Nuvation Bio's CFO Jennifer Fox Resigns	11-13	MT
Nuvation Bio Inc. Announces Formation of Oncology-Focused Scientific Advisory Board	01/06/23	CI
Insider Buy: Nuvation Bio	05/12/22	MT
Nuvation Bio Inc. Appoints David Liu as Chief Medical Officer and Kerry Wentworth as Chief Regulatory Officer	18/07/22	CI
Nuvation Bio Inc. Announces Resignation of Michelle Doig from the Board of Directors	04/06/21	CI
Nuvation Bio Appoints David C. Hanley, as Chief Technical Operations Officer	01/06/21	CI
Nuvation Bio Inc. and Panacea Acquisition Corp. Announce Management Team for the Combined Company	10/02/21	CI
Panacea Acquisition Corp. has Changed its Name to Nuvation Bio Inc	09/02/21	CI
Nuvation Bio Announces the Appointment of Jennifer Fox as its Chief Financial Officer	26/10/20	CI
Nuvation Bio, Inc. Announces Management Changes	21/10/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer